References
- Gencer S, Salepci T, Ozer S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J Infect 2003;47:65–72.
- Kelly S, Wheatley D. Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors. Br J Cancer 2009;101(Suppl. 1):S6–S10.
- Cullen M, Baijal S. Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer 2009;101(Suppl. 1):S11–S14.
- Krell D, Jones AL. Impact of effective prevention and management of febrile neutropenia. Br J Cancer 2009;101(Suppl. 1):S23–S26.
- Hämäläinen S, Kuittinen T, Matinlauri I, . Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 2008;49:495–501.
- Hämäläinen S, Kuittinen T, Matinlauri I, . Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scand J Infect Dis 2009;41:14–20.
- Kumar A, Roberts D, Wood KE, . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596.
- Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15.
- Shapiro NI, Schuetz P, Yano K, . The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010;14:R182.
- Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008;29:328–333.
- Shapiro NI, Trzeciak S, Hollander JE, . A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009;37:96–104.
- Karlsson S, Heikkinen M, Pettilä V, . Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010;14:R205.
- Nguyen HB, Rivers EP, Knoblich BP, . Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004;32:1637–1642.
- Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008;36:213–219.
- von Lilienfeld-Toal M, Schneider A, Orlopp K, . Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 2006; 14:1241–1245.
- Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest 2005;128:2864–2875.
- Sakr Y, Sponholz C, Tuche F, . The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008; 36:396–407.
- Persson L, Engervall P, Magnuson A, . Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004;36:365–371.
- Yonemori K, Kanda Y, Yamamoto R, . Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients. Leuk Lymphoma 2001;41:607–614.
- Hughes WT, Armstrong D, Bodey GP, . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–751.
- Levy MM, Fink MP, Marshall JC, . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–538.
- Bone RC, Balk RA, Cerra FB, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009;136(5 Suppl.):e28.
- Comrey AL. A first course in factor analysis. New York: Academic Press, Inc.; 1973.
- Charles PE, Ladoire S, Aho S, . Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008;8:38.
- Hämäläinen S, Juutilainen A, Kuittinen T, . Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leuk Lymphoma 2010;51:1040–1046.
- Juutilainen A, Hämäläinen S, Matinlauri I, . Serial plasma lactate measurements in haematological patients with neutropenic fever. Scand J Infect Dis 2010;42:102–108.
- Matinlauri I, Juutilainen A, Hämäläinen S, . Fibrinogen and antithrombin in hematological patients with neutropenic fever. CEJMed 2010;5:520–526.
- Koivula I, Hämäläinen S, Jantunen E, . Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis 2011;43:471–478.
- Prat C, Sancho JM, Dominguez J, . Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 2008;49:1752–1761.
- Jeddi R, Achour M, Amor RB, . Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes. Hematology 2010;15:28–32.
- Miedema KG, de Bont ES, Elferink RF, . The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer 2010 Aug 28. [Epub ahead of print].